# Finerenone

## Kerendia film-coated 20mg

| TAH Drug Code      | [OKER2](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OKER2)                                                                                                                                                                                                                                                                                                                                                                                              |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | For adults with chronic kidney disease (CKD) related to type 2 diabetes (T2D), it reduces the risk of sustained eGFR decline, end-stage kidney disease (ESKD), cardiovascular death, non-fatal myocardial infarction, and heart failure hospitalization.                                                                                                                                                                                                            |
| Dosing             | Initial: 20 mg once daily. Maintenance Dose: (Current dose 10 mg once daily): K<=4.8, increase to 20 mg once daily. K>4.8 to 5.5, continue 10 mg once daily. K>5.5, interrupt therapy. May consider restarting at 10 mg once daily when serum potassium ?5 mEq/L. (Current dose 20 mg once daily): K<=4.8, continue 20 mg once daily. K>4.8 to 5.5, continue 20 mg once daily. K>5.5, interrupt therapy. Restart at 10 mg once daily when serum potassium ?5 mEq/L. |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Contraindications  | Concomitant treatment with strong CYP3A4 inhibitors; adrenal insufficiency.                                                                                                                                                                                                                                                                                                                                                                                         |
| Adverse Effects    | >10%: Endocrine & metabolic: Hyperkalemia (14%) 1% to 10%: Cardiovascular: Hypotension (5%) Endocrine & metabolic: Hyponatremia (1%)                                                                                                                                                                                                                                                                                                                                |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| More Info          | [UpToDate](https://www.uptodate.com/contents/finerenone-drug-information)                                                                                                                                                                                                                                                                                                                                                                                           |

